Publications

Tap into Gubra’s vast production of publications and posters to get the latest knowledge and insights within our focus areas: diabetes, obesity, NASH and gastrointestinal diseases.

LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men

Cell Reports Medicine 3(4):100582, 2022

Hageman CA, Jensen MS, Holm S, Gasbjerg LS, Byberg S, Skov-Jeppesen K, Hartmann B, Holst JJ, Dela F, Vilsbøll T, Christensen MB, Holst B, Knop FK

Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis

Scientific Reports 12(1):6666, 2022

Nestor JJ, Parkes D, Feigh M, Suschak J, Harris MS

Digital brain maps and virtual neuroscience. An emerging role for light sheet fluorescence microscopy in drug development

Frontiers in Neuroscience 16:866884, 2022

Perens J, Hecksher-Sørensen J

Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

Clinical and Translational Science 15(5):1167-1186, 2022

Møllerhøj MB, Veidal SS, Thrane KT, Oró D, Overgaard A, Salinas CG, Madsen MR, Pfisterer L, Vyberg M, Simon E, Broermann A, Vrang N, Jelsing J, Feigh M, Hansen HH

Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect

Scientific Reports 12:1696, 2022

Alexopoulou F, Bech EM, Pedersen SL, Thorbek DD, Leurs U, Rudkjær LCB, Fosgerau K, Hansen HH, Vrang N, Jelsing J, Elster L

Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese-diabetic mice improves insulin sensitivity associated with recovered pancreatic ß-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries

Molecular Metabolism 55:101392, 2021

Boland BB, O’Brien S, Sermadiras I, Nielsen JC, Barkholt P, Roostalu U, Hecksher-Sørensen J, Sejthen SR, Thorbek DD, Suckow A, Burmeister N, Oldham S, Will S, Howard VG, Gill BM , Newton P, Naylor J, Sitaula S, Laker RC, Hornigold DC, Austin J, Lantier L, McGuiness OP, Trevaskis JL, Grimsby JS, Rhodes CJ

Integrative transcriptomic profiling of a mouse model of hypertension-accelerated diabetic kidney disease

Disease Models & Mechanisms 14(10): dmm049086, 2021

Sembach FE, Ægidius HM, Fink LN, Secher T, Aarup A, Jelsing J, Vrang N, Feldt-Rasmussen B, Rigbolt KTG, Nielsen JC, Østergaard MV

Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease

American Journal of Physiology-Renal Physiology 321(2):F149-F161, 2021

Østergaard MV, Secher T, Christensen M, Salinas CG, Roostalu U, Skytte JL, Rune I, Hansen HH, Jelsing J, Vrang N, Fink LN

Empagliflozin improves metabolic and hepatic outcomes in a non-diabetic obese biopsy-proven mouse model of advanced NASH

International Journal of Molecular Sciences 22:6332, 2021

Perakakis N, Chrysafi P, Feigh M, Veidal SS, Mantzoros CS

Comparative study of voxel-based statistical analysis methods for fluorescently labelled and light sheet imaged whole-brain samples

Proceedings of the 2021 IEEE 18th International Symposium on Biomedical Imaging, p. 1433-1437

Johanna Perens, Jacob Lercke Skytte, Casper Gravesen Salinas, Jacob Hecksher-Sørensen, Tim B Dyrby, Anders Bjorholm Dahl

Whole-brain mapping of amylin-induced neuronal activity in receptor activity–modifying protein (RAMP) 1/3 knockout mice

European Journal of Neuroscience 54:4154-4166, 2021

Skovbjerg G, Roostalu U, Hansen HH, Lutz T, Le Foll C, Salinas CG, Skytte JL, Jelsing J, Vrang N, Hecksher-Sørensen J

Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese mice

Scientific Reports 11:8060, 2021

Hansen HH, Grønlund RV, Baader-Pagler T, Haebel P, Tammen H, Kongskov Larsen L, Jelsing J, Vrang N, Klein T

Chronic peptide-based GIP receptor inhibition exhibits modest glucose metabolic changes in mice when administered either alone or combined with GLP-1 agonism

PLoS One 16(3):e0249239, 2021

West JA, Tsakmaki A, Ghosh SS, Parkes DG, Grønlund RV, Pedersen PJ, Maggs D, Rajagopalan H, Bewick GA

Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitis

Liver International 41(8):1853-1866, 2021

Perakakis N, Stefanakis K, Feigh M, Veidal SS, Mantzoros CS

A genetic map of the mouse dorsal vagal complex and its role in obesity

Nature Metabolism 3(4):530-545, 2021

Ludwig MQ, Cheng W, Gordian D, Lee J, Paulsen SJ, Hansen SN, Egerod KL, Barkholt P, Rhodes CJ, Secher A, Knudsen LB, Pyke C, Myers MG Jr, Pers TH

Effect of captopril on post-infarction remodelling visualized by light sheet microscopy and echocardiography

Scientific Reports 11(1):5241, 2021

Roostalu U, Thisted L, Skytte JL, Salinas CG, Pedersen PJ, Hecksher-Sørensen J, Rolin B, Hansen HH, Mackrell JG, Christie RM, Vrang N, Jelsing J, Zois NE

Activation of thyroid hormone receptor-β improved disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis

British Journal of Pharmacology 178(12):2412-2423, 2021

Kannt A, Wohlfart P, Madsen AN, Veidal SS, Feigh M, Schmoll D

Interferon lambda 4 genotype and pathway in alcoholic hepatitis

Scandinavian Journal of Gastroenterology 56(3):304-311, 2021

Støy S, Terczynska-Dyla E, Veidal SS, Rigbolt K, Vilstrup H, Grønbæk H, Hartmann R, Sandahl TD

Whole-brain activation signatures of weight-lowering drugs

Molecular Metabolism 101171, 2021

Hansen HH, Perens J, Roostalu U, Skytte JL, Salinas CG, Barkholt P, Thorbek DD, Rigbolt KTG, Vrang N, Jelsing J, Hecksher-Sørensen J

Deep learning reveals 3D atherosclerotic plaque distribution and composition

Scientific Reports 10(1):21523, 2020

Jurtz VI, Skovbjerg G, Salinas CG, Roostalu U, Pedersen L, Hecksher-Sørensen J, Rolin B, Nyberg M, van de Bunt M, Ingvorsen C

Transcriptomic changes in pancreatic islets, adipose and liver after Roux-en-Y gastric bypass in a diet-induced obese rat model

Peptides 136:170467, 2020

Zhang C, Biehl Rudkjær LC, Cachón MF, Falkenhahn M, Theis S, Schmidt T, Vrang N, Jelsing J, Rigbolt K

An aldehyde responsive, cleavable linker for glucose responsive insulins

Chemistry 27:1-12, 2021

Mannerstedt K, Mishra NK, Engholm E, Lundh M, Madsen CS, Pedersen PJ, Le-Huu P, Pedersen SL, Buch-Månson N, Borgström B, Brimert T, Fink LN, Fosgerau K, Vrang N, Jensen KJ

Characterization of local gut microbiome and intestinal transcriptome responses to rosiglitazone treatment in db/db mice

Biomedicine & Pharmacotherapy 133:110966

Madsen MSM, Grønlund RV, Christensen-Dalsgaard M, Sommer M, Jelsing J, Vrang N, Rigbolt K, Madsen MR, Hansen HH, Mikkelsen M

3D quantification of changes in pancreatic islets in mouse models of diabetes type I and II

Disease Models & Mechanisms 13(12):dmm045351, 2020

Roostalu U, Skytte JL, Salinas CG, Klein T, Vrang T, Jelsing J, Hecksher-Sørensen J

Gut mucosal gene expression and metabolic changes after Roux-en-Y gastric bypass surgery

Obesity 28(11): 2163-2174, 2020

Jorsal T, Christensen MM, Mortensen B, Nygaard EB, Zhang C, Rigbolt K, Falkenhahn M, Wandall E, Langholz E, Friis S, Worm D, Floyd A, Helgstrand F, Støving RK, Aldries AR, Juhl CB, Østergaard T, Rydborg T, Forman JL, Sørensen F, Schmidt T, Falkenhahn M, Musholt PB, Theis S, Larsen PJ, Rehfeld JF, Vrang N, Jelsing J, Vilsbøll T, Knop FK

Identification and metabolic profiling of a novel human gut-derived LEAP2 fragment

Journal of Clinical Endocrinology and Metabolism 106(2):e966-e981, 2021

Hagemann CA, Zhang C, Hansen HH, Jorsal T, Rigbolt KTG, Madsen MR, Bergmann NC, Heimbürger SMN, Falkenhahn M, Theis S, Breitschopf K, Holm S, Hedegaard MA, Christensen MB, Vilsbøll T, Holst B, Vrang N, Jelsing J, Knop FK

An optimized mouse brain atlas for automated mapping and quantification of neuronal activity using iDISCO+ and light sheet fluorescence microscopy

Neuroinformatics [online ahead of print]

Perens J, Salinas CG, Skytte JL, Roostalu U, Dahl AB, Dyrby TB, Wichern F, Barkholt P, Vrang N, Jelsing J, Hecksher-Sørensen J

Rat pancreatectomy combined with isoprenaline or uninephrectomy as models of diabetic cardiomyopathy or nephropathy

Scientific Reports 10:16130, 2020

Thisted L, Østergaard MV, Pedersen AA, Pedersen PJ, Lindsay RT, Murray AJ, Fink LN, Pedersen TX, Secher T, Johansen TT, Thrane ST, Skarsfeldt T, Jelsing J, Thomsen MB, Zois NE

Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative

Liver International 40:2860-2876, 2020

Stokman G, van den Hoek AM, Thorbek DD, Pieterman EJ, Veidal SS, Basta B, Iruarrizaga-Lejarreta M, van der Hoorn JW, Verschuren L, Berbée JFP, Rensen PCN, Skjæret T, Alonso C, Feigh M, Kastelein JJP, Friedman SL, Princen HMG, Fraser DA

Low interleukin-22 binding protein is associated with high mortality in alcoholic hepatitis and modulates interleukin-22 receptor expression

Clinical and Translational Gastroenterology 11(8):e00197

Støy S, Laursen TL, Glavind E, Lykke Eriksen P, Terczynska-Dyla E, Magnusson NE, Hamilton-Dutoit S, Mortensen F, Veidal SS, Rigbolt K, Oliviero R, Deleuran B, Vilstrup H, Sandahl TD

Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis

BMC Gastroenterology 20:210, 2020

Hansen HH, Ægidius HM, Oró D, Evers S, Heebøll S, Eriksen PL, Bengtsson A, Veidal SS, Feigh M, Knop FK, Grønbæk H, Miranda D, Trevaskis JL, Vrang N, Jelsing J, Rigbolt KTG

The selective peroxisome proliferator‐activated receptor gamma modulator CHS‐131 improves liver histopathology and metabolism in a mouse model of obesity and nonalcoholic steatohepatitis

Hepatology Communications 4(9):1302-1315, 2020

Perakakis P, Joshi A, Peradze N, Stefanakis K,Li G, Feigh M, Veidal SS, Rosen G, Fleming M, Mantzoros CS

Automated image analyses of glomerular hypertrophy in a mouse model of diabetic nephropathy

Kidney360 1(6): 469-479, 2020

Østergaard MV, Sembach FE, Skytte JL, Roostalu U, Secher T, Overgaard A, Fink LN, Vrang N, Jelsing J, Hecksher-Sørensen J

Whole-brain 3D imaging for quantification of drug targets and treatment effects in mouse models of neurodegenerative diseases

Neural Regeneration Research 15(12):2255-2257, 2020

Hansen HH, Roostalu U, Hecksher-Sørensen J

Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis

Nature Metabolism 2(5):413–431, 2020

Boland ML, Laker RC, Mather K, Nawrocki A, Oldham S, Boland BB, Lewis H, Conway J, Naylor J, Guionaud S, Feigh M, Veidal SS, Lantier L, McGuinness OP, Grimsby J, Rondinone CM, Jermutus L, Larsen MR, Trevaskis JL, Rhodes CJ

Activation of adenosine monophosphate-activated protein kinase reduces the onset of diet-induced hepatocellular carcinoma in mice

Hepatology Communications 4(7):1056-1072, 2020

Schmoll D, Ziegler N, Viollet B, Foretz M, Even PC, Azzout-Marniche D, Madsen AN, Illemann M, Egebjerg KM, Feigh M, Czech J, Glombik H, Olsen JA, Hennerici W, Steinmeyer K, Elvert R, Castañeda TR, Kannt A

Rodent models of diabetic kidney disease: human translatability and preclinical validity

Drug Discovery Today 26(1):200-217, 2021

Sembach FE, Østergaard MV, Vrang N, Feldt-Rasmussen B, Fosgerau K, Jelsing J, Fink LN

Incretin combination therapy for the treatment of non-alcoholic steatohepatitis

Diabetes, Obesity and Metabolism 22(8):1328-1338, 2020

Kannt A, Nygaard Madsen A, Kammermeier C, Elvert R, Klöckener T, Bossart M, Haack T, Evers A, Lorenz K, Hennerici W, Rocher C, Böcskei Z, Guillemot JC, Mikol V, Pattou F, Staels B, Wagner M

Glucagon resistance at the level of amino acid turnover in obese subjects with hepatic steatosis

Diabetes 69(6):1090-1099, 2020

Suppli MP, Bagger JI, Lund A, Demant M, van Hall G, Strandberg C, Kønig MJ, Rigbolt K, Langhoff JL, Albrechtsen NJW, Holst JJ, Vilsbøll T, Knop FK

Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis

Scientific Reports 10(1):1148, 2020

Ægidius HM, Veidal SS, Feigh M, Hallenborg P, Puglia M, Vrang N, Jelsing J, Kornum BR, Blagoev B, Rigbolt KTG

Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH

BMC Gastroenterology 19(1):228, 2019

Kristiansen MB, Veidal SS, Christoffersen C, Feigh M, Hansen HH, Vrang N, Roth JD, Erickson M, Young M, Adorini L, Jelsing J

Impact of sex on diabetic nephropathy and the renal transcriptome in UNx db/db C57BLKS mice

Physiology Reports 7(24):e14333, 2019

Sembach FE, Fink LN, Johansen T, Boland BB, Secher T, Thrane ST, Nielsen JC, Fosgerau K, Vrang N, Jelsing J, Pedersen TX, Østergaard MV

Quantitative whole-brain 3D imaging of tyrosine hydroxylase-labeled neuron architecture in the mouse MPTP model of Parkinson's disease

Disease Models & Mechanisms 12(11):dmm042200, 2019

Roostalu U, Salinas CBG, Thorbek DD, Skytte JL, Fabricius K, Barkholt P, John LM, Jurtz VI, Knudsen LB, Jelsing J, Vrang N, Hansen HH, Hecksher-Sørensen J

The dorsomedial hypothalamus and nucleus of the solitary tract as key regulators in a rat model of chronic obesity

Brain Research 1727:146538, 2020

Zhang C, Barkholt P, Nielsen JC, Thorbek DD, Rigbolt K, Vrang N, Woldbye DPD, Jelsing J

Global transcriptome analysis of rat hypothalamic arcuate nucleus demonstrates reversal of hypothalamic gliosis following surgically and diet induced weight loss

Scientific Reports 9(1):16161, 2019

Barkholt P, Rigbolt KTG, Zhang C, Falkenhahn M, Hübschle T, Schwahn U, Fernandez-Cachon ML, Schmidt T, Theis S, Hansen HH, Hay-Schmidt A, Pedersen PJ, Vrang N, Jelsing J

Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice

Scientific Reports 9(1):15582, 2019

Madsen MSA, Holm JB, Pallejà A, Sommer M, Wismann P, Fabricius K, Rigbolt K, Mikkelsen M, Jelsing J, Vrang N, Hansen HH

Mastiha (Pistacia Lentiscus) improves gut microbiota diversity, hepatic steatosis and disease activity in a biopsy-confirmed mouse model of advanced non-alcoholic steatohepatitis and fibrosis

Molecular Nutrition & Food Research 63(24):e1900927, 2019

Kannt A, Papada E, Kammermeier C, D'Auria G, Jiménez-Hernández N, Stephan M, Schwahn U, Madsen AN, Ostergaard MV, Dedoussis G; MAST4HEALTH consortium

Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source

World Journal of Gastroenterology 25(33):4904-4920, 2019

Boland ML, Oró D, Tølbøl KS, Thrane ST, Nielsen JC, Cohen TS, Tabor DE, Fernandes F, Tovchigrechko A, Veidal SS, Warrener P, Sellman BR, Jelsing J, Feigh M, Vrang N, Trevaskis JL, Hansen HH

Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion

Liver International 39(11):2094-2101, 2019

Eriksen PL, Vilstrup H, Rigbolt K, Suppli MP, Sørensen M, Heebøll S, Veidal SS, Knop FK, Thomsen KL

Half-Life extending modifications of peptide YY3-36 direct receptor-mediated internalization

Molecular Pharmaceutics 16(8):3665-3677, 2019

Bech EM, Kaiser A, Bellmann-Sickert K, Nielsen SS, Sørensen KK, Elster L, Hatzakis N, Pedersen SL, Beck-Sickinger AG, Jensen KJ

Investigating intestinal glucagon after Roux-en-Y gastric bypass surgery

Journal of Clinical Endocrinology & Metabolism 104(12):6403-6416, 2019

Jorsal T, Wewer Albrechtsen NJ, Christensen MM, Mortensen B, Wandall E, Langholz E, Friis S, Worm D, Ørskov C, Støving RK, Andries A, Juhl CB, Sørensen F, Forman JL, Falkenhahn M, Musholt PB, Theis S, Larsen PJ, Holst JJ, Vrang N, Jelsing J, Vilsbøll T, Knop FK

RhoA in tyrosine hydroxylase neurons regulates food intake and body weight via altered sensitivity to peripheral hormones

Journal of Neuroendocrinology 31(7):e12761, 2019

Skov LJ, Ratner C, Hansen NW, Thompson JJ, Egerod KL, Burm H, Dalbøge LS, Hedegaard MA, Brakebusch C, Pers TH, Perrier JF, Holst B

Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH

Scientific Reports 9(1):9046, 2019

Roth JD, Veidal SS, Fensholdt LKD, Rigbolt KTG, Papazyan R, Nielsen JC, Feigh M, Vrang N, Young M, Jelsing J, Adorini L, Hansen HH

The preprohormone expression profile of enteroendocrine cells following Roux-en-Y gastric bypass in rats

Peptides 118:170100, 2019

Zhang C, Rigbolt K, Petersen SL, Biehl Rudkjær LC, Schwahn U, Fernandez-Cachon ML, Bossart M, Falkenhahn M, Theis S, Hübschle T, Schmidt T, Just Larsen P, Vrang N, Jelsing J

Hepatic molecular characteristics of patients with varying degrees of nonalcoholic steatohepatitis compared to healthy normal weight individuals

American Journal of Physiology - Gastroenterology and Liver Physiology 316(4):G462-G472, 2019

Suppli M, Rigbolt KTG, Veidal SS, Heebøll S, Demant M, Bagger JI, Thrane SW, Nielsen JC, Lund A, Strandberg C, Vilsbøll T, Vrang N, Grønbæk H, Jelsing J, Hansen HH, Knop FK

Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes

Journal of Translational Medicine 17:110, 2019

Schumacher‑Petersen C, Christofersen BØ, Kirk RK, Ludvigsen TP, Zois NE, Pedersen HD, Vyberg M, Olsen LH

Animal models of type 2 diabetes, obesity and nonalcoholic steatohepatitis – clinical translatability and applicability in preclinical drug development

In: Krentz A., Weyer C., Hompesch M. (eds) Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. Springer, Cham. pp 369-403, 2019

Hansen HH, Hansen G, Secher T, Feigh M, Veidal SS, Fosgerau K, Jelsing J, Vrang N

The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach

Molecular Metabolism 21:36-50, 2019

Raichur S, Brunner B, Bielohuby M, Hansen G, Pfenninger A, Wang B, Bruning JC, Larsen PJ, Tennagels N

Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects

World Journal of Hepatology 11(2):138-149, 2019

Laursen TL, Hagemann CA, Wei C, Kazankov K, Thomsen KL, Knop FK, Grønbæk H

Pancreatic β-cell rest replenishes insulin secretory capacity and attenuates diabetes in an extreme model of obese type 2 diabetes

Diabetes 68(1):131-140, 2019

Boland B, Brown C, Boland ML, Cann J, Sulikowski M, Hansen G, Grønlund RV, King W, Rondinone C, Trevaskis J, Rhodes CJ, Grimsby JS

Adrenomedullin and glucagon-like peptide-1 have additive effects on food intake in mice

Biomedicine & Pharmacotherapy 109:167-173, 2019

Bech EM, Voldum-Clausen K, Pedersen SL, Fabricius K, Rudkjær LCB, Hansen HH, Jelsing J

Molecular characterization of microvesicular and macrovesicular steatosis shows widespread differences in metabolic pathways

Lipids 54(1):109-115, 2019

Kristiansen MNB, Veidal SS, Christoffersen C, Jelsing J, Rigbolt KTG

Disease progression and pharmacological intervention in a nutrient-deficient rat model of nonalcoholic steatohepatitis

Digestive Diseases and Sciences 64(5):1238-1256, 2019

Tølbøl KS, Stierstorfer B, Rippmann J, Veidal SS, Rigbolt KGT, Gillum MP, Hansen HH, Jelsing J, Vrang N, Feigh M, Broermann A

Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice

Physiology and Behavior 192:72-81, 2018

Wismann P, Pedersen SL, Hansen G, Mannerstedt K, Pedersen PJ, Jeppesen PB, Vrang N, Fosgerau K, Jelsing J

Chemical Strategies for Half-life Extension of Biopharmaceuticals: Lipidation and its Alternatives

ACS Medicinal Chemistry Letters 9(7):577-580, 2018

Bech EM, Pedersen SL, Jensen K

Guanylin and uroguanylin mRNA expression is increased following Roux-en-Y gastric bypass, but guanylins do not play a significant role in body weight regulation and glycemic control

Peptides 101:32–43, 2018

Fernandez-Cachon ML, Pedersen SL, Rigbolt KT, Zhang C, Fabricius K, Hansen HH, Elster L, Fink LN, Schäfer M, Rhee NA, Langholz E, Wandall E, Friis SU, Vilmann P, Kristiansen VB, Schmidt C, Schreiter K, Breitschopf K, Hübschle T, Jorsal T, Vilsbøll T, Schmidt T, Theis S, Knop FK, Larsen PJ, Jelsing J

INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis

World Journal of Gastroenterology 24(2):195–210, 2018

Jonathan D. Roth, Michael Feigh, Sanne S. Veidal, Louise K.D. Fensholdt, Kristoffer T. Rigbolt, Henrik H. Hansen, Li C. Chen, Mathieu Petitjean, Weslyn Friley, Niels Vrang, Jacob Jelsing, Mark Young

Metabolic and hepatic effects of liraglutide, obeticholic acid and elafbranor in diet-induced obese mouse models of biopsy-confrmed nonalcoholic steatohepatitis

World Journal of Gastroenterology 24(2):179–194, 2018

Tølbøl KS, Kristiansen MN, Hansen HH, Veidal SS, Rigbolt KT, Gillum MP, Jelsing J, Vrang N, Feigh M

Application of the physical disector principle for quantification of dopaminergic neuronal loss in a rat 6-hydroxydopamine nigral lesion model of Parkinson’s disease

Frontiers in Neuroanatomy 11:109, 2017

Fabricius K, Barkholt P, Jelsing J, Hansen HH

GUB06-046, a novel secretin/glucagon-like peptide 1 co-agonist, decreases food intake, improves glycemic control, and preserves beta cell mass in diabetic mice

Journal of Peptide Science 23(12):845–854, 2017

van Witteloostuijn SB, Dalbøge LS, Hansen G, Midtgaard SR, Jensen GV, Jensen KJ, Vrang N, Jelsing J, Pedersen SL

In-vitro and in-vivo studies supporting the therapeutic potential of ZP3022 in diabetes

European Journal of Pharmacology 815:181–189, 2017

Skarbaliene J, Rigbolt KT, Fosgerau K, Billestrup N

Mouse models of nonalcoholic steatohepatitis in preclinical drug development

Drug Discovery Today 22(11):1707–1718, 2017

Hansen HH, Feigh M, Veidal SS, Rigbolt KT, Vrang N, Fosgerau K.

Enteroendocrine K and L cells in healthy and type 2 diabetic individuals

Diabetologia 61(2):284–294, 2017

Jorsal T, Rhee NA, Pedersen J, Wahlgren CD, Mortensen B, Jepsen SL, Jelsing J, Dalbøge LS, Vilmann P, Hassan H, Hendel JW, Poulsen SS, Holst JJ, Vilsbøll T, Knop FK

Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) Analogues

Journal of Medicinal Chemistry 60(17):7434–7446, 2017

Bech EM, Martos-Maldonado MC, Wismann P, Sørensen KK, van Witteloostuijn SB, Thygesen MB, Vrang N, Jelsing J, Pedersen SL, Jensen KJ

A hydrogel-microsphere drug delivery system that supports once-monthly administration of a GLP-1 receptor agonist

ACS Chemical Biology 12(8):2107–2116, 2017

Schneider EL, Hearn BR, Pfaff SJ, Reid R, Parkes DG, Vrang N, Ashley GW, Santi DV

Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia

Kidney International 92(1):165–178, 2017

Mace ML, Gravesen E, Nordholm A, Hofman-Bang J, Secher T, Olgaard K, Lewin E

Neurturin and a GLP-1 analogue act synergistically to alleviate diabetes in Zucker diabetic fatty rats

Diabetes 66(7):2007–2018, 2017

Trevaskis JL, Sacramento CB, Jouihan H, Ali S, Le Lay J, Oldham S, Bhagroo N, Boland BB, Cann J, Chang Y, O'Day T, Howard V, Reers C, Winzell MS, Smith DM, Feigh M, Barkholt P, Schreiter K, Austen M, Andag U, Thompson S, Jermutus L, Coghlan MP, Grimsby J, Dohrmann C, Rhodes CJ, Rondinone CM, Sharma A

Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model

Brain Research 1665:22–35, 2017

Helboe L, Egebjerg J, Barkholt P, Volbracht C

The endogenous preproglucagon system is not essential for gut growth homeostasis in mice

Molecular Metabolism 6(7):681–692, 2017

Wismann P, Barkholt P, Secher T, Vrang N, Hansen HB, Jeppesen PB, Baggio LL, Koehler JA, Drucker DJ, Sandoval DA, Jelsing J.

Neoglycolipids for prolonging the effects of peptides: Self-assembling glucagon-like peptide 1 analogues with albumin binding properties and potent in vivo efficacy

Molecular Pharmacology 14(1):193–205, 2017

van Witteloostuijn SB, Mannerstedt K, Wismann P, Bech EM, Thygesen MB, Vrang N, Jelsing J, Jensen KJ, Pedersen SL

Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates

Diabetes Obesity and Metabolism 18(12):1176–1190, 2016

Henderson SJ, Konkar A, Hornigold DC, Trevaskis JL, Jackson R, Fritsch Fredin M, Jansson-Löfmark R, Naylor J, Rossi A, Bednarek MA, Bhagroo N, Salari H, Will S, Oldham S, Hansen G, Feigh M, Klein T, Grimsby J, Maguire S, Jermutus L, Rondinone CM, Coghlan MP

Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation

ChemMedChem 11(22):2474–2495, 2016

van Witteloostuijn SB, Pedersen SL, Jensen KJ

Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson’s disease

Brain Research 1646:354–365, 2016

Hansen HH, Fabricius K, Barkholt P, Mikkelsen JD, Jelsing J, Pyke C, Knudsen LB, Vrang N

Effects of Peripheral Neurotensin on Appetite Regulation and Its Role in Gastric Bypass Surgery

Endocrinology 157(9):3482–92, 2016

Ratner C, Skov LJ, Raida Z, Bächler T, Bellmann-Sickert K, Le Foll C, Sivertsen B, Dalbøge LS, Hartmann B, Beck-Sickinger AG, Madsen AN, Jelsing J, Holst JJ, Lutz TA, Andrews ZB, Holst B

Long-term treatment with liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has no effect on β-amyloid plaque load in two transgenic APP/PS1 mouse models of Alzheimer’s disease

PLOS One 11(7):e0158205, 2016

Hansen HH, Fabricius K, Barkholt P, Kongsbak-Wismann P, Schlumberger C, Jelsing J, Terwel D, Termont A, Pyke C, Knudsen LB, Vrang N.

Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy

World Journal of Hepatology 8(16):673-684, 2016

Maria Nicoline Baandrup Kristiansen, Sanne Skovgård Veidal, Kristoffer Tobias Gustav Rigbolt, Kirstine Sloth Tølbøl, Jacob Jelsing, Niels Vrang, Michael Feigh

The IL-1β receptor antagonist SER140 postpones the onset of diabetes in female nonobese diabetic mice

Journal of Diabetes Research 2016:7484601, 2016

Cucak H, Hansen G, Vrang N, Skarsfeldt T, Steiness E, Jelsing J.

Rapid gut growth but persistent delay in digestive function in the postnatal period of preterm pigs

American Journal of Physiology - Gastrointestinal and Liver Physiology 310(8):G550-560, 2016

Hansen CF, Thymann T, Andersen AD, Holst JJ, Hartmann B, Hilsted L, Langhorn L, Jelsing J, Sangild PT

The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy

Brain Research 1634:158–170, 2016

Hansen HH, Barkholt P, Fabricius K, Jelsing J, Terwel D, Pyke C, Knudsen LB, Vrang N

Alterations in hypothalamic gene expression following Roux-en-Y gastric bypass

Molecular Metabolism 5(4):296-304, 2016

Barkholt P, Pedersen PJ, Hay-Schmidt A, Jelsing J, Hansen HH, Vrang N.

Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes

Diabetologia 58(10):2254–8, 2015

Rhee NA, Wahlgren CD, Pedersen J, Mortensen B, Langholz E, Wandall EP, Friis SU, Vilmann P, Paulsen SJ, Kristiansen VB, Jelsing J, Dalbøge LS, Poulsen SS, Holst JJ, Vilsbøll T, Knop FK

A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents

PLOS One 10(8):e0135634, 2015

Dalbøge LS, Pedersen PJ, Hansen G, Fabricius K, Hansen HB, Jelsing J, Vrang N.

Neuromedin U inhibits food intake partly by inhibiting gastric emptying

Peptides 69:56–65, 2015

Dalbøge LS, Pedersen SL, Secher T, Holst B, Vrang N, Jelsing J.

The anti-diabetic effects of GLP-1-gastrin dual agonist ZP3022 in ZDF rats

Peptides 69:47–55, 2015

Skarbaliene J, Secher T, Jelsing J, Ansarullah, Neerup TS, Billestrup N, Fosgerau K

The GLP-1 receptor agonist liraglutide improves memory function and increases hippocampal CA1 neuronal numbers in a senescence-accelerated mouse model of Alzheimer's disease

Journal of Alzheimers Disease 46(4):877–88, 2015

Hansen HH, Fabricius K, Barkholt P, Niehoff ML, Morley JE, Jelsing J, Pyke C, Knudsen LB, Farr SA, Vrang N.

Glucagon-like peptide-1 receptor agonists increase pancreatic mass by induction of protein synthesis

Diabetes 64(3):1046–56, 2015

Koehler JA, Baggio LL, Cao X, Abdulla T, Campbell JE, Secher T, Jelsing J, Larsen B, Drucker DJ

Synthesis and evaluation of novel lipidated neuromedin U analogs with increased stability and effects on food intake

Journal of Peptide Science 21(2):85–94, 2015

Dalbøge LS, Pedersen SL, van Witteloostuijn SB, Rasmussen JE, Rigbolt KT, Jensen KJ, Holst B, Vrang N, Jelsing J

Expression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) Brain

Endocrinology 156(1):255–267, 2015

Heppner KM, Kirigiti M, Secher A, Paulsen SJ, Buckingham R, Pyke C, Knudsen LB, Vrang N, Grove KL.

Post-surgical effects of Roux-en-Y gastric bypass on glucose homeostasis, intestinal morphology and L-cells in obese Göttingen minipigs

Journal of Obesity and Bariatrics 1(1):8, 2015

Barkholt P, Vegge A, Clausen TR, Birck MM, Fels JJ, Støckel M, Gögenur I, Eriksen T, Holst JJ, Hansen AK, Thymann T, Jelsing J, Sangild PT, Raun K

The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat

European Journal of Pharmacology 741:254-263, 2014

Hansen HH, Hansen G, Paulsen S, Vrang N, Mark M, Jelsing J, Klein T

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

Journal of Clinical Investigation 124(10):4473-4488, 2014

Secher A, Jelsing J, Baquero AF, Hecksher-Sørensen J, Cowley MA, Dalbøge LS, Hansen G, Grove KL, Pyke C, Raun K, Schäffer L, Tang-Christensen M, Verma S, Witgen BM, Vrang N, Bjerre Knudsen L.

The sodium glucose cotransporter type 2 inhibitor empagliflozin preserves β-cell mass and restores glucose homeostasis in the male zucker diabetic fatty rat

The Journal of Pharmacology and Experimental Therapeutics 350(3):657–664, 2014

Hansen HH, Jelsing J, Hansen CF, Hansen G, Vrang N, Mark M, Klein T, Mayoux E.

The novel GLP-1-gastrin dual agonist ZP3022 improves glucose homeostasis and increases β-cell mass without affecting islet number in db/db mice

The Journal of Pharmacology and Experimental Therapeutics 350(2):353–360, 2014

Dalbøge LS, Almholt DL, Neerup TS, Vrang N, Jelsing J, Fosgerau K.

Expression of the fatty acid receptor GPR120 in the gut of diet-induced-obese rats and its role in GLP-1 secretion

PLOS One 9(2):e88227, 2014

Paulsen SJ, Larsen LK, Hansen G, Chelur S, Larsen PJ, Vrang N.

The effect of ileal interposition surgery on enteroendocrine cell numbers in the UC Davis type 2 diabetes mellitus rat

Regulatory Peptides 189:31–9, 2014

Hansen CF, Vassiliadis E, Vrang N, Sangild PT, Cummings BP, Havel P, Jelsing J

Characterisation of age-dependent beta cell dynamics in the male db/db mice

PLOS One 8(12):e82813, 2013

Dalbøge LS, Almholt DL, Neerup TS, Vassiliadis E, Vrang N, Pedersen L, Fosgerau K, Jelsing J.

Instruments for automated peptide synthesis

In: Knud J. Jensen et al. (eds.), Peptide Synthesis and Applications, Methods in Molecular Biology, 1047:215–24, 2013

Pedersen SL, Jensen KJ

Peptide release, side-chain deprotection, work-up, and isolation

In: Knud J. Jensen et al. (eds.), Peptide Synthesis and Applications, Methods in Molecular Biology, 1047:43–63, 2013

Pedersen SL, Jensen KJ

Hypertrophy dependent doubling of L-cells in Roux-en-Y gastric bypass operated rats

PLOS One 8(6):e65696, 2013

Hansen CF, Bueter M, Theis N, Lutz T, Paulsen S, Dalbøge LS, Vrang N, Jelsing J.

Novel insight into the distribution of L-cells in the rat intestinal tract

American Journal of Translational Research 5(3):347–58, 2013

Hansen CF, Vrang N, Sangild PT, Jelsing J.

Improving membrane binding as a design strategy for amphipathic peptide hormones: 2-helixvariants of PYY3-36

Journal of Peptide Science 18(9):579-587, 2012

Pedersen SL, Bhatia VK, Jurt S, Paulsson JF, Pedersen MH, Jorgensen R, Holst B, Stamou D, Vrang N, Zerbe O, Jensen KJ

The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic mice

Journal of Endocrinology 214(3):381–387, 2012

Jelsing J, Vrang N, van Witteloostuijn SB, Mark M, Klein T.

The effects of 13 wk of liraglutide treatment on endocrine and exocrine pancreas in male and female ZDF rats: a quantitative and qualitative analysis revealing no evidence of drug-induced pancreatitis

American Journal of Physiolology - Endocrinology and Metabolism 303:E253-E264, 2012

Vrang N, Jelsing J, Simonsen L, Jensen AE, Thorup I, Søeborg H, Knudsen LB

Liraglutide: short-lived effect on gastric emptying - long lasting effects on body weight

Diabetes Obesity & Metabolism 14(6):531–538, 2012

Jelsing J, Vrang N, Hansen G, Raun K, Tang-Christensen M, Knudsen LB

Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats

Acta Pharmacologica Sinica 33:194–200, 2012

Hansen G, Jelsing J, Vrang N.

Laser capture microdissection and quantitative-PCR analysis

In: Adalberto Merighi (ed.), Neuropeptides: Methods and Protocols, Methods in Molecular Biology 789:127–35, 2011

Paulsen SJ, Larsen LK

The brainstem preproglucagon system in a non-human primate (Macaca mulatta)

Brain Research 1397:28–37, 2011

Vrang N, Grove K

Stereological assessment of pancreatic beta-cell mass development in male Zucker Diabetic Fatty (ZDF) rats: correlation with pancreatic beta-cell function

Journal of Anatomy 217(5):624-630, 2010

Paulsen SJ, Vrang N, Larsen LK, Larsen PJ, Jelsing J.

Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides

Progress in Neurobiology 92(3):442–462, 2010

Vrang N, Larsen PJ

The imprinted gene neuronatin is regulated by metabolic status and associated with obesity

Obesity (Silver Spring) 18(7):1289–1296, 2010

Vrang N, Meyre D, Froguel P, Jelsing J, Tang-Christensen M, Vatin V, Mikkelsen JD, Thirstrup K, Larsen LK, Cullberg KB, Fahrenkrug J, Jacobson P, Sjöström L, Carlsson LM, Liu Y, Liu X, Deng HW, Larsen PJ

The effect of leptin receptor deficiency and fasting on cannabinoid receptor 1 mRNA expression in the rat hypothalamus, brainstem and nodose ganglion

Neuroscience Letters 463(2):125–129, 2009

Jelsing J, Larsen PJ, Vrang N

Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2

Brain Research Bulletin 78:202–10, 2009

Jelsing J, Galzin AM, Guillot E, Pruniaux MP, Larsen PJ, Vrang N

Featured publications

Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease

American Journal of Physiology-Renal Physiology 321(2):F149-F161, 2021

Østergaard MV, Secher T, Christensen M, Salinas CG, Roostalu U, Skytte JL, Rune I, Hansen HH, Jelsing J, Vrang N, Fink LN

Whole-brain activation signatures of weight-lowering drugs

Molecular Metabolism 101171, 2021

Hansen HH, Perens J, Roostalu U, Skytte JL, Salinas CG, Barkholt P, Thorbek DD, Rigbolt KTG, Vrang N, Jelsing J, Hecksher-Sørensen J

An aldehyde responsive, cleavable linker for glucose responsive insulins

Chemistry 27:1-12, 2021

Mannerstedt K, Mishra NK, Engholm E, Lundh M, Madsen CS, Pedersen PJ, Le-Huu P, Pedersen SL, Buch-Månson N, Borgström B, Brimert T, Fink LN, Fosgerau K, Vrang N, Jensen KJ

3D quantification of changes in pancreatic islets in mouse models of diabetes type I and II

Disease Models & Mechanisms 13(12):dmm045351, 2020

Roostalu U, Skytte JL, Salinas CG, Klein T, Vrang T, Jelsing J, Hecksher-Sørensen J

Identification and metabolic profiling of a novel human gut-derived LEAP2 fragment

Journal of Clinical Endocrinology and Metabolism 106(2):e966-e981, 2021

Publications

Tap into Gubra’s vast production of publications and posters to get the latest knowledge and insights within our focus areas: diabetes, obesity, NASH and gastrointestinal diseases.

Featured publications

Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease

American Journal of Physiology-Renal Physiology 321(2):F149-F161, 2021

Østergaard MV, Secher T, Christensen M, Salinas CG, Roostalu U, Skytte JL, Rune I, Hansen HH, Jelsing J, Vrang N, Fink LN

Whole-brain activation signatures of weight-lowering drugs

Molecular Metabolism 101171, 2021

Hansen HH, Perens J, Roostalu U, Skytte JL, Salinas CG, Barkholt P, Thorbek DD, Rigbolt KTG, Vrang N, Jelsing J, Hecksher-Sørensen J

An aldehyde responsive, cleavable linker for glucose responsive insulins

Chemistry 27:1-12, 2021

Mannerstedt K, Mishra NK, Engholm E, Lundh M, Madsen CS, Pedersen PJ, Le-Huu P, Pedersen SL, Buch-Månson N, Borgström B, Brimert T, Fink LN, Fosgerau K, Vrang N, Jensen KJ

3D quantification of changes in pancreatic islets in mouse models of diabetes type I and II

Disease Models & Mechanisms 13(12):dmm045351, 2020

Roostalu U, Skytte JL, Salinas CG, Klein T, Vrang T, Jelsing J, Hecksher-Sørensen J

Identification and metabolic profiling of a novel human gut-derived LEAP2 fragment

Journal of Clinical Endocrinology and Metabolism 106(2):e966-e981, 2021

LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men

Cell Reports Medicine 3(4):100582, 2022

Hageman CA, Jensen MS, Holm S, Gasbjerg LS, Byberg S, Skov-Jeppesen K, Hartmann B, Holst JJ, Dela F, Vilsbøll T, Christensen MB, Holst B, Knop FK

Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis

Scientific Reports 12(1):6666, 2022

Nestor JJ, Parkes D, Feigh M, Suschak J, Harris MS

Digital brain maps and virtual neuroscience. An emerging role for light sheet fluorescence microscopy in drug development

Frontiers in Neuroscience 16:866884, 2022

Perens J, Hecksher-Sørensen J

Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

Clinical and Translational Science 15(5):1167-1186, 2022

Møllerhøj MB, Veidal SS, Thrane KT, Oró D, Overgaard A, Salinas CG, Madsen MR, Pfisterer L, Vyberg M, Simon E, Broermann A, Vrang N, Jelsing J, Feigh M, Hansen HH

Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect

Scientific Reports 12:1696, 2022

Alexopoulou F, Bech EM, Pedersen SL, Thorbek DD, Leurs U, Rudkjær LCB, Fosgerau K, Hansen HH, Vrang N, Jelsing J, Elster L

Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese-diabetic mice improves insulin sensitivity associated with recovered pancreatic ß-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries

Molecular Metabolism 55:101392, 2021

Integrative transcriptomic profiling of a mouse model of hypertension-accelerated diabetic kidney disease

Disease Models & Mechanisms 14(10): dmm049086, 2021

Sembach FE, Ægidius HM, Fink LN, Secher T, Aarup A, Jelsing J, Vrang N, Feldt-Rasmussen B, Rigbolt KTG, Nielsen JC, Østergaard MV

Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease

American Journal of Physiology-Renal Physiology 321(2):F149-F161, 2021

Østergaard MV, Secher T, Christensen M, Salinas CG, Roostalu U, Skytte JL, Rune I, Hansen HH, Jelsing J, Vrang N, Fink LN

Empagliflozin improves metabolic and hepatic outcomes in a non-diabetic obese biopsy-proven mouse model of advanced NASH

International Journal of Molecular Sciences 22:6332, 2021

Perakakis N, Chrysafi P, Feigh M, Veidal SS, Mantzoros CS

Comparative study of voxel-based statistical analysis methods for fluorescently labelled and light sheet imaged whole-brain samples

Proceedings of the 2021 IEEE 18th International Symposium on Biomedical Imaging, p. 1433-1437

Johanna Perens, Jacob Lercke Skytte, Casper Gravesen Salinas, Jacob Hecksher-Sørensen, Tim B Dyrby, Anders Bjorholm Dahl

Whole-brain mapping of amylin-induced neuronal activity in receptor activity–modifying protein (RAMP) 1/3 knockout mice

European Journal of Neuroscience 54:4154-4166, 2021

Skovbjerg G, Roostalu U, Hansen HH, Lutz T, Le Foll C, Salinas CG, Skytte JL, Jelsing J, Vrang N, Hecksher-Sørensen J

Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese mice

Scientific Reports 11:8060, 2021

Hansen HH, Grønlund RV, Baader-Pagler T, Haebel P, Tammen H, Kongskov Larsen L, Jelsing J, Vrang N, Klein T

Chronic peptide-based GIP receptor inhibition exhibits modest glucose metabolic changes in mice when administered either alone or combined with GLP-1 agonism

PLoS One 16(3):e0249239, 2021

West JA, Tsakmaki A, Ghosh SS, Parkes DG, Grønlund RV, Pedersen PJ, Maggs D, Rajagopalan H, Bewick GA

Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitis

Liver International 41(8):1853-1866, 2021

Perakakis N, Stefanakis K, Feigh M, Veidal SS, Mantzoros CS

A genetic map of the mouse dorsal vagal complex and its role in obesity

Nature Metabolism 3(4):530-545, 2021

Ludwig MQ, Cheng W, Gordian D, Lee J, Paulsen SJ, Hansen SN, Egerod KL, Barkholt P, Rhodes CJ, Secher A, Knudsen LB, Pyke C, Myers MG Jr, Pers TH

Effect of captopril on post-infarction remodelling visualized by light sheet microscopy and echocardiography

Scientific Reports 11(1):5241, 2021

Roostalu U, Thisted L, Skytte JL, Salinas CG, Pedersen PJ, Hecksher-Sørensen J, Rolin B, Hansen HH, Mackrell JG, Christie RM, Vrang N, Jelsing J, Zois NE

Activation of thyroid hormone receptor-β improved disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis

British Journal of Pharmacology 178(12):2412-2423, 2021

Kannt A, Wohlfart P, Madsen AN, Veidal SS, Feigh M, Schmoll D

Interferon lambda 4 genotype and pathway in alcoholic hepatitis

Scandinavian Journal of Gastroenterology 56(3):304-311, 2021

Støy S, Terczynska-Dyla E, Veidal SS, Rigbolt K, Vilstrup H, Grønbæk H, Hartmann R, Sandahl TD

Whole-brain activation signatures of weight-lowering drugs

Molecular Metabolism 101171, 2021

Hansen HH, Perens J, Roostalu U, Skytte JL, Salinas CG, Barkholt P, Thorbek DD, Rigbolt KTG, Vrang N, Jelsing J, Hecksher-Sørensen J

Deep learning reveals 3D atherosclerotic plaque distribution and composition

Scientific Reports 10(1):21523, 2020

Jurtz VI, Skovbjerg G, Salinas CG, Roostalu U, Pedersen L, Hecksher-Sørensen J, Rolin B, Nyberg M, van de Bunt M, Ingvorsen C

Transcriptomic changes in pancreatic islets, adipose and liver after Roux-en-Y gastric bypass in a diet-induced obese rat model

Peptides 136:170467, 2020

Zhang C, Biehl Rudkjær LC, Cachón MF, Falkenhahn M, Theis S, Schmidt T, Vrang N, Jelsing J, Rigbolt K

An aldehyde responsive, cleavable linker for glucose responsive insulins

Chemistry 27:1-12, 2021

Mannerstedt K, Mishra NK, Engholm E, Lundh M, Madsen CS, Pedersen PJ, Le-Huu P, Pedersen SL, Buch-Månson N, Borgström B, Brimert T, Fink LN, Fosgerau K, Vrang N, Jensen KJ

Characterization of local gut microbiome and intestinal transcriptome responses to rosiglitazone treatment in db/db mice

Biomedicine & Pharmacotherapy 133:110966

Madsen MSM, Grønlund RV, Christensen-Dalsgaard M, Sommer M, Jelsing J, Vrang N, Rigbolt K, Madsen MR, Hansen HH, Mikkelsen M

3D quantification of changes in pancreatic islets in mouse models of diabetes type I and II

Disease Models & Mechanisms 13(12):dmm045351, 2020

Roostalu U, Skytte JL, Salinas CG, Klein T, Vrang T, Jelsing J, Hecksher-Sørensen J

Gut mucosal gene expression and metabolic changes after Roux-en-Y gastric bypass surgery

Obesity 28(11): 2163-2174, 2020

Identification and metabolic profiling of a novel human gut-derived LEAP2 fragment

Journal of Clinical Endocrinology and Metabolism 106(2):e966-e981, 2021

An optimized mouse brain atlas for automated mapping and quantification of neuronal activity using iDISCO+ and light sheet fluorescence microscopy

Neuroinformatics [online ahead of print]

Perens J, Salinas CG, Skytte JL, Roostalu U, Dahl AB, Dyrby TB, Wichern F, Barkholt P, Vrang N, Jelsing J, Hecksher-Sørensen J

Rat pancreatectomy combined with isoprenaline or uninephrectomy as models of diabetic cardiomyopathy or nephropathy

Scientific Reports 10:16130, 2020

Thisted L, Østergaard MV, Pedersen AA, Pedersen PJ, Lindsay RT, Murray AJ, Fink LN, Pedersen TX, Secher T, Johansen TT, Thrane ST, Skarsfeldt T, Jelsing J, Thomsen MB, Zois NE

Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative

Liver International 40:2860-2876, 2020

Low interleukin-22 binding protein is associated with high mortality in alcoholic hepatitis and modulates interleukin-22 receptor expression

Clinical and Translational Gastroenterology 11(8):e00197

Støy S, Laursen TL, Glavind E, Lykke Eriksen P, Terczynska-Dyla E, Magnusson NE, Hamilton-Dutoit S, Mortensen F, Veidal SS, Rigbolt K, Oliviero R, Deleuran B, Vilstrup H, Sandahl TD

Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis

BMC Gastroenterology 20:210, 2020

Hansen HH, Ægidius HM, Oró D, Evers S, Heebøll S, Eriksen PL, Bengtsson A, Veidal SS, Feigh M, Knop FK, Grønbæk H, Miranda D, Trevaskis JL, Vrang N, Jelsing J, Rigbolt KTG

The selective peroxisome proliferator‐activated receptor gamma modulator CHS‐131 improves liver histopathology and metabolism in a mouse model of obesity and nonalcoholic steatohepatitis

Hepatology Communications 4(9):1302-1315, 2020

Perakakis P, Joshi A, Peradze N, Stefanakis K,Li G, Feigh M, Veidal SS, Rosen G, Fleming M, Mantzoros CS

Automated image analyses of glomerular hypertrophy in a mouse model of diabetic nephropathy

Kidney360 1(6): 469-479, 2020

Østergaard MV, Sembach FE, Skytte JL, Roostalu U, Secher T, Overgaard A, Fink LN, Vrang N, Jelsing J, Hecksher-Sørensen J

Whole-brain 3D imaging for quantification of drug targets and treatment effects in mouse models of neurodegenerative diseases

Neural Regeneration Research 15(12):2255-2257, 2020

Hansen HH, Roostalu U, Hecksher-Sørensen J

Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis

Nature Metabolism 2(5):413–431, 2020

Activation of adenosine monophosphate-activated protein kinase reduces the onset of diet-induced hepatocellular carcinoma in mice

Hepatology Communications 4(7):1056-1072, 2020

Rodent models of diabetic kidney disease: human translatability and preclinical validity

Drug Discovery Today 26(1):200-217, 2021

Sembach FE, Østergaard MV, Vrang N, Feldt-Rasmussen B, Fosgerau K, Jelsing J, Fink LN

Incretin combination therapy for the treatment of non-alcoholic steatohepatitis

Diabetes, Obesity and Metabolism 22(8):1328-1338, 2020

Kannt A, Nygaard Madsen A, Kammermeier C, Elvert R, Klöckener T, Bossart M, Haack T, Evers A, Lorenz K, Hennerici W, Rocher C, Böcskei Z, Guillemot JC, Mikol V, Pattou F, Staels B, Wagner M

Glucagon resistance at the level of amino acid turnover in obese subjects with hepatic steatosis

Diabetes 69(6):1090-1099, 2020

Suppli MP, Bagger JI, Lund A, Demant M, van Hall G, Strandberg C, Kønig MJ, Rigbolt K, Langhoff JL, Albrechtsen NJW, Holst JJ, Vilsbøll T, Knop FK

Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis

Scientific Reports 10(1):1148, 2020

Ægidius HM, Veidal SS, Feigh M, Hallenborg P, Puglia M, Vrang N, Jelsing J, Kornum BR, Blagoev B, Rigbolt KTG

Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH

BMC Gastroenterology 19(1):228, 2019

Kristiansen MB, Veidal SS, Christoffersen C, Feigh M, Hansen HH, Vrang N, Roth JD, Erickson M, Young M, Adorini L, Jelsing J

Impact of sex on diabetic nephropathy and the renal transcriptome in UNx db/db C57BLKS mice

Physiology Reports 7(24):e14333, 2019

Sembach FE, Fink LN, Johansen T, Boland BB, Secher T, Thrane ST, Nielsen JC, Fosgerau K, Vrang N, Jelsing J, Pedersen TX, Østergaard MV

Quantitative whole-brain 3D imaging of tyrosine hydroxylase-labeled neuron architecture in the mouse MPTP model of Parkinson's disease

Disease Models & Mechanisms 12(11):dmm042200, 2019

Roostalu U, Salinas CBG, Thorbek DD, Skytte JL, Fabricius K, Barkholt P, John LM, Jurtz VI, Knudsen LB, Jelsing J, Vrang N, Hansen HH, Hecksher-Sørensen J

The dorsomedial hypothalamus and nucleus of the solitary tract as key regulators in a rat model of chronic obesity

Brain Research 1727:146538, 2020

Zhang C, Barkholt P, Nielsen JC, Thorbek DD, Rigbolt K, Vrang N, Woldbye DPD, Jelsing J

Global transcriptome analysis of rat hypothalamic arcuate nucleus demonstrates reversal of hypothalamic gliosis following surgically and diet induced weight loss

Scientific Reports 9(1):16161, 2019

Barkholt P, Rigbolt KTG, Zhang C, Falkenhahn M, Hübschle T, Schwahn U, Fernandez-Cachon ML, Schmidt T, Theis S, Hansen HH, Hay-Schmidt A, Pedersen PJ, Vrang N, Jelsing J

Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice

Scientific Reports 9(1):15582, 2019

Madsen MSA, Holm JB, Pallejà A, Sommer M, Wismann P, Fabricius K, Rigbolt K, Mikkelsen M, Jelsing J, Vrang N, Hansen HH

Mastiha (Pistacia Lentiscus) improves gut microbiota diversity, hepatic steatosis and disease activity in a biopsy-confirmed mouse model of advanced non-alcoholic steatohepatitis and fibrosis

Molecular Nutrition & Food Research 63(24):e1900927, 2019

Kannt A, Papada E, Kammermeier C, D'Auria G, Jiménez-Hernández N, Stephan M, Schwahn U, Madsen AN, Ostergaard MV, Dedoussis G; MAST4HEALTH consortium

Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source

World Journal of Gastroenterology 25(33):4904-4920, 2019

Boland ML, Oró D, Tølbøl KS, Thrane ST, Nielsen JC, Cohen TS, Tabor DE, Fernandes F, Tovchigrechko A, Veidal SS, Warrener P, Sellman BR, Jelsing J, Feigh M, Vrang N, Trevaskis JL, Hansen HH

Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion

Liver International 39(11):2094-2101, 2019

Eriksen PL, Vilstrup H, Rigbolt K, Suppli MP, Sørensen M, Heebøll S, Veidal SS, Knop FK, Thomsen KL

Half-Life extending modifications of peptide YY3-36 direct receptor-mediated internalization

Molecular Pharmaceutics 16(8):3665-3677, 2019

Bech EM, Kaiser A, Bellmann-Sickert K, Nielsen SS, Sørensen KK, Elster L, Hatzakis N, Pedersen SL, Beck-Sickinger AG, Jensen KJ

Investigating intestinal glucagon after Roux-en-Y gastric bypass surgery

Journal of Clinical Endocrinology & Metabolism 104(12):6403-6416, 2019

RhoA in tyrosine hydroxylase neurons regulates food intake and body weight via altered sensitivity to peripheral hormones

Journal of Neuroendocrinology 31(7):e12761, 2019

Skov LJ, Ratner C, Hansen NW, Thompson JJ, Egerod KL, Burm H, Dalbøge LS, Hedegaard MA, Brakebusch C, Pers TH, Perrier JF, Holst B

Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH

Scientific Reports 9(1):9046, 2019

Roth JD, Veidal SS, Fensholdt LKD, Rigbolt KTG, Papazyan R, Nielsen JC, Feigh M, Vrang N, Young M, Jelsing J, Adorini L, Hansen HH

The preprohormone expression profile of enteroendocrine cells following Roux-en-Y gastric bypass in rats

Peptides 118:170100, 2019

Zhang C, Rigbolt K, Petersen SL, Biehl Rudkjær LC, Schwahn U, Fernandez-Cachon ML, Bossart M, Falkenhahn M, Theis S, Hübschle T, Schmidt T, Just Larsen P, Vrang N, Jelsing J

Hepatic molecular characteristics of patients with varying degrees of nonalcoholic steatohepatitis compared to healthy normal weight individuals

American Journal of Physiology - Gastroenterology and Liver Physiology 316(4):G462-G472, 2019

Suppli M, Rigbolt KTG, Veidal SS, Heebøll S, Demant M, Bagger JI, Thrane SW, Nielsen JC, Lund A, Strandberg C, Vilsbøll T, Vrang N, Grønbæk H, Jelsing J, Hansen HH, Knop FK

Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes

Journal of Translational Medicine 17:110, 2019

Schumacher‑Petersen C, Christofersen BØ, Kirk RK, Ludvigsen TP, Zois NE, Pedersen HD, Vyberg M, Olsen LH

Animal models of type 2 diabetes, obesity and nonalcoholic steatohepatitis – clinical translatability and applicability in preclinical drug development

In: Krentz A., Weyer C., Hompesch M. (eds) Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. Springer, Cham. pp 369-403, 2019

Hansen HH, Hansen G, Secher T, Feigh M, Veidal SS, Fosgerau K, Jelsing J, Vrang N

The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach

Molecular Metabolism 21:36-50, 2019

Raichur S, Brunner B, Bielohuby M, Hansen G, Pfenninger A, Wang B, Bruning JC, Larsen PJ, Tennagels N

Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects

World Journal of Hepatology 11(2):138-149, 2019

Laursen TL, Hagemann CA, Wei C, Kazankov K, Thomsen KL, Knop FK, Grønbæk H

Pancreatic β-cell rest replenishes insulin secretory capacity and attenuates diabetes in an extreme model of obese type 2 diabetes

Diabetes 68(1):131-140, 2019

Boland B, Brown C, Boland ML, Cann J, Sulikowski M, Hansen G, Grønlund RV, King W, Rondinone C, Trevaskis J, Rhodes CJ, Grimsby JS

Adrenomedullin and glucagon-like peptide-1 have additive effects on food intake in mice

Biomedicine & Pharmacotherapy 109:167-173, 2019

Bech EM, Voldum-Clausen K, Pedersen SL, Fabricius K, Rudkjær LCB, Hansen HH, Jelsing J

Molecular characterization of microvesicular and macrovesicular steatosis shows widespread differences in metabolic pathways

Lipids 54(1):109-115, 2019

Kristiansen MNB, Veidal SS, Christoffersen C, Jelsing J, Rigbolt KTG

Disease progression and pharmacological intervention in a nutrient-deficient rat model of nonalcoholic steatohepatitis

Digestive Diseases and Sciences 64(5):1238-1256, 2019

Tølbøl KS, Stierstorfer B, Rippmann J, Veidal SS, Rigbolt KGT, Gillum MP, Hansen HH, Jelsing J, Vrang N, Feigh M, Broermann A

Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice

Physiology and Behavior 192:72-81, 2018

Wismann P, Pedersen SL, Hansen G, Mannerstedt K, Pedersen PJ, Jeppesen PB, Vrang N, Fosgerau K, Jelsing J

Chemical Strategies for Half-life Extension of Biopharmaceuticals: Lipidation and its Alternatives

ACS Medicinal Chemistry Letters 9(7):577-580, 2018

Bech EM, Pedersen SL, Jensen K

Guanylin and uroguanylin mRNA expression is increased following Roux-en-Y gastric bypass, but guanylins do not play a significant role in body weight regulation and glycemic control

Peptides 101:32–43, 2018

INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis

World Journal of Gastroenterology 24(2):195–210, 2018

Jonathan D. Roth, Michael Feigh, Sanne S. Veidal, Louise K.D. Fensholdt, Kristoffer T. Rigbolt, Henrik H. Hansen, Li C. Chen, Mathieu Petitjean, Weslyn Friley, Niels Vrang, Jacob Jelsing, Mark Young

Metabolic and hepatic effects of liraglutide, obeticholic acid and elafbranor in diet-induced obese mouse models of biopsy-confrmed nonalcoholic steatohepatitis

World Journal of Gastroenterology 24(2):179–194, 2018

Tølbøl KS, Kristiansen MN, Hansen HH, Veidal SS, Rigbolt KT, Gillum MP, Jelsing J, Vrang N, Feigh M

Application of the physical disector principle for quantification of dopaminergic neuronal loss in a rat 6-hydroxydopamine nigral lesion model of Parkinson’s disease

Frontiers in Neuroanatomy 11:109, 2017

Fabricius K, Barkholt P, Jelsing J, Hansen HH

GUB06-046, a novel secretin/glucagon-like peptide 1 co-agonist, decreases food intake, improves glycemic control, and preserves beta cell mass in diabetic mice

Journal of Peptide Science 23(12):845–854, 2017

van Witteloostuijn SB, Dalbøge LS, Hansen G, Midtgaard SR, Jensen GV, Jensen KJ, Vrang N, Jelsing J, Pedersen SL

In-vitro and in-vivo studies supporting the therapeutic potential of ZP3022 in diabetes

European Journal of Pharmacology 815:181–189, 2017

Skarbaliene J, Rigbolt KT, Fosgerau K, Billestrup N

Mouse models of nonalcoholic steatohepatitis in preclinical drug development

Drug Discovery Today 22(11):1707–1718, 2017

Hansen HH, Feigh M, Veidal SS, Rigbolt KT, Vrang N, Fosgerau K.

Enteroendocrine K and L cells in healthy and type 2 diabetic individuals

Diabetologia 61(2):284–294, 2017

Jorsal T, Rhee NA, Pedersen J, Wahlgren CD, Mortensen B, Jepsen SL, Jelsing J, Dalbøge LS, Vilmann P, Hassan H, Hendel JW, Poulsen SS, Holst JJ, Vilsbøll T, Knop FK

Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) Analogues

Journal of Medicinal Chemistry 60(17):7434–7446, 2017

Bech EM, Martos-Maldonado MC, Wismann P, Sørensen KK, van Witteloostuijn SB, Thygesen MB, Vrang N, Jelsing J, Pedersen SL, Jensen KJ

A hydrogel-microsphere drug delivery system that supports once-monthly administration of a GLP-1 receptor agonist

ACS Chemical Biology 12(8):2107–2116, 2017

Schneider EL, Hearn BR, Pfaff SJ, Reid R, Parkes DG, Vrang N, Ashley GW, Santi DV

Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia

Kidney International 92(1):165–178, 2017

Mace ML, Gravesen E, Nordholm A, Hofman-Bang J, Secher T, Olgaard K, Lewin E

Neurturin and a GLP-1 analogue act synergistically to alleviate diabetes in Zucker diabetic fatty rats

Diabetes 66(7):2007–2018, 2017

Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model

Brain Research 1665:22–35, 2017

Helboe L, Egebjerg J, Barkholt P, Volbracht C

The endogenous preproglucagon system is not essential for gut growth homeostasis in mice

Molecular Metabolism 6(7):681–692, 2017

Wismann P, Barkholt P, Secher T, Vrang N, Hansen HB, Jeppesen PB, Baggio LL, Koehler JA, Drucker DJ, Sandoval DA, Jelsing J.

Neoglycolipids for prolonging the effects of peptides: Self-assembling glucagon-like peptide 1 analogues with albumin binding properties and potent in vivo efficacy

Molecular Pharmacology 14(1):193–205, 2017

van Witteloostuijn SB, Mannerstedt K, Wismann P, Bech EM, Thygesen MB, Vrang N, Jelsing J, Jensen KJ, Pedersen SL

Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates

Diabetes Obesity and Metabolism 18(12):1176–1190, 2016

Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation

ChemMedChem 11(22):2474–2495, 2016

van Witteloostuijn SB, Pedersen SL, Jensen KJ

Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson’s disease

Brain Research 1646:354–365, 2016

Hansen HH, Fabricius K, Barkholt P, Mikkelsen JD, Jelsing J, Pyke C, Knudsen LB, Vrang N

Effects of Peripheral Neurotensin on Appetite Regulation and Its Role in Gastric Bypass Surgery

Endocrinology 157(9):3482–92, 2016

Ratner C, Skov LJ, Raida Z, Bächler T, Bellmann-Sickert K, Le Foll C, Sivertsen B, Dalbøge LS, Hartmann B, Beck-Sickinger AG, Madsen AN, Jelsing J, Holst JJ, Lutz TA, Andrews ZB, Holst B

Long-term treatment with liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has no effect on β-amyloid plaque load in two transgenic APP/PS1 mouse models of Alzheimer’s disease

PLOS One 11(7):e0158205, 2016

Hansen HH, Fabricius K, Barkholt P, Kongsbak-Wismann P, Schlumberger C, Jelsing J, Terwel D, Termont A, Pyke C, Knudsen LB, Vrang N.

Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy

World Journal of Hepatology 8(16):673-684, 2016

Maria Nicoline Baandrup Kristiansen, Sanne Skovgård Veidal, Kristoffer Tobias Gustav Rigbolt, Kirstine Sloth Tølbøl, Jacob Jelsing, Niels Vrang, Michael Feigh

The IL-1β receptor antagonist SER140 postpones the onset of diabetes in female nonobese diabetic mice

Journal of Diabetes Research 2016:7484601, 2016

Cucak H, Hansen G, Vrang N, Skarsfeldt T, Steiness E, Jelsing J.

Rapid gut growth but persistent delay in digestive function in the postnatal period of preterm pigs

American Journal of Physiology - Gastrointestinal and Liver Physiology 310(8):G550-560, 2016

Hansen CF, Thymann T, Andersen AD, Holst JJ, Hartmann B, Hilsted L, Langhorn L, Jelsing J, Sangild PT

The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy

Brain Research 1634:158–170, 2016

Hansen HH, Barkholt P, Fabricius K, Jelsing J, Terwel D, Pyke C, Knudsen LB, Vrang N

Alterations in hypothalamic gene expression following Roux-en-Y gastric bypass

Molecular Metabolism 5(4):296-304, 2016

Barkholt P, Pedersen PJ, Hay-Schmidt A, Jelsing J, Hansen HH, Vrang N.

Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes

Diabetologia 58(10):2254–8, 2015

Rhee NA, Wahlgren CD, Pedersen J, Mortensen B, Langholz E, Wandall EP, Friis SU, Vilmann P, Paulsen SJ, Kristiansen VB, Jelsing J, Dalbøge LS, Poulsen SS, Holst JJ, Vilsbøll T, Knop FK

A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents

PLOS One 10(8):e0135634, 2015

Dalbøge LS, Pedersen PJ, Hansen G, Fabricius K, Hansen HB, Jelsing J, Vrang N.

Neuromedin U inhibits food intake partly by inhibiting gastric emptying

Peptides 69:56–65, 2015

Dalbøge LS, Pedersen SL, Secher T, Holst B, Vrang N, Jelsing J.

The anti-diabetic effects of GLP-1-gastrin dual agonist ZP3022 in ZDF rats

Peptides 69:47–55, 2015

Skarbaliene J, Secher T, Jelsing J, Ansarullah, Neerup TS, Billestrup N, Fosgerau K

The GLP-1 receptor agonist liraglutide improves memory function and increases hippocampal CA1 neuronal numbers in a senescence-accelerated mouse model of Alzheimer's disease

Journal of Alzheimers Disease 46(4):877–88, 2015

Hansen HH, Fabricius K, Barkholt P, Niehoff ML, Morley JE, Jelsing J, Pyke C, Knudsen LB, Farr SA, Vrang N.

Glucagon-like peptide-1 receptor agonists increase pancreatic mass by induction of protein synthesis

Diabetes 64(3):1046–56, 2015

Koehler JA, Baggio LL, Cao X, Abdulla T, Campbell JE, Secher T, Jelsing J, Larsen B, Drucker DJ

Synthesis and evaluation of novel lipidated neuromedin U analogs with increased stability and effects on food intake

Journal of Peptide Science 21(2):85–94, 2015

Dalbøge LS, Pedersen SL, van Witteloostuijn SB, Rasmussen JE, Rigbolt KT, Jensen KJ, Holst B, Vrang N, Jelsing J

Expression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) Brain

Endocrinology 156(1):255–267, 2015

Heppner KM, Kirigiti M, Secher A, Paulsen SJ, Buckingham R, Pyke C, Knudsen LB, Vrang N, Grove KL.

Post-surgical effects of Roux-en-Y gastric bypass on glucose homeostasis, intestinal morphology and L-cells in obese Göttingen minipigs

Journal of Obesity and Bariatrics 1(1):8, 2015

Barkholt P, Vegge A, Clausen TR, Birck MM, Fels JJ, Støckel M, Gögenur I, Eriksen T, Holst JJ, Hansen AK, Thymann T, Jelsing J, Sangild PT, Raun K

The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat

European Journal of Pharmacology 741:254-263, 2014

Hansen HH, Hansen G, Paulsen S, Vrang N, Mark M, Jelsing J, Klein T

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

Journal of Clinical Investigation 124(10):4473-4488, 2014

Secher A, Jelsing J, Baquero AF, Hecksher-Sørensen J, Cowley MA, Dalbøge LS, Hansen G, Grove KL, Pyke C, Raun K, Schäffer L, Tang-Christensen M, Verma S, Witgen BM, Vrang N, Bjerre Knudsen L.

The sodium glucose cotransporter type 2 inhibitor empagliflozin preserves β-cell mass and restores glucose homeostasis in the male zucker diabetic fatty rat

The Journal of Pharmacology and Experimental Therapeutics 350(3):657–664, 2014

Hansen HH, Jelsing J, Hansen CF, Hansen G, Vrang N, Mark M, Klein T, Mayoux E.

The novel GLP-1-gastrin dual agonist ZP3022 improves glucose homeostasis and increases β-cell mass without affecting islet number in db/db mice

The Journal of Pharmacology and Experimental Therapeutics 350(2):353–360, 2014

Dalbøge LS, Almholt DL, Neerup TS, Vrang N, Jelsing J, Fosgerau K.

Expression of the fatty acid receptor GPR120 in the gut of diet-induced-obese rats and its role in GLP-1 secretion

PLOS One 9(2):e88227, 2014

Paulsen SJ, Larsen LK, Hansen G, Chelur S, Larsen PJ, Vrang N.

The effect of ileal interposition surgery on enteroendocrine cell numbers in the UC Davis type 2 diabetes mellitus rat

Regulatory Peptides 189:31–9, 2014

Hansen CF, Vassiliadis E, Vrang N, Sangild PT, Cummings BP, Havel P, Jelsing J

Characterisation of age-dependent beta cell dynamics in the male db/db mice

PLOS One 8(12):e82813, 2013

Dalbøge LS, Almholt DL, Neerup TS, Vassiliadis E, Vrang N, Pedersen L, Fosgerau K, Jelsing J.

Instruments for automated peptide synthesis

In: Knud J. Jensen et al. (eds.), Peptide Synthesis and Applications, Methods in Molecular Biology, 1047:215–24, 2013

Pedersen SL, Jensen KJ

Peptide release, side-chain deprotection, work-up, and isolation

In: Knud J. Jensen et al. (eds.), Peptide Synthesis and Applications, Methods in Molecular Biology, 1047:43–63, 2013

Pedersen SL, Jensen KJ

Hypertrophy dependent doubling of L-cells in Roux-en-Y gastric bypass operated rats

PLOS One 8(6):e65696, 2013

Hansen CF, Bueter M, Theis N, Lutz T, Paulsen S, Dalbøge LS, Vrang N, Jelsing J.

Novel insight into the distribution of L-cells in the rat intestinal tract

American Journal of Translational Research 5(3):347–58, 2013

Hansen CF, Vrang N, Sangild PT, Jelsing J.

Improving membrane binding as a design strategy for amphipathic peptide hormones: 2-helixvariants of PYY3-36

Journal of Peptide Science 18(9):579-587, 2012

Pedersen SL, Bhatia VK, Jurt S, Paulsson JF, Pedersen MH, Jorgensen R, Holst B, Stamou D, Vrang N, Zerbe O, Jensen KJ

The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic mice

Journal of Endocrinology 214(3):381–387, 2012

Jelsing J, Vrang N, van Witteloostuijn SB, Mark M, Klein T.

The effects of 13 wk of liraglutide treatment on endocrine and exocrine pancreas in male and female ZDF rats: a quantitative and qualitative analysis revealing no evidence of drug-induced pancreatitis

American Journal of Physiolology - Endocrinology and Metabolism 303:E253-E264, 2012

Vrang N, Jelsing J, Simonsen L, Jensen AE, Thorup I, Søeborg H, Knudsen LB

Liraglutide: short-lived effect on gastric emptying - long lasting effects on body weight

Diabetes Obesity & Metabolism 14(6):531–538, 2012

Jelsing J, Vrang N, Hansen G, Raun K, Tang-Christensen M, Knudsen LB

Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats

Acta Pharmacologica Sinica 33:194–200, 2012

Hansen G, Jelsing J, Vrang N.

Laser capture microdissection and quantitative-PCR analysis

In: Adalberto Merighi (ed.), Neuropeptides: Methods and Protocols, Methods in Molecular Biology 789:127–35, 2011

Paulsen SJ, Larsen LK

The brainstem preproglucagon system in a non-human primate (Macaca mulatta)

Brain Research 1397:28–37, 2011

Vrang N, Grove K

Stereological assessment of pancreatic beta-cell mass development in male Zucker Diabetic Fatty (ZDF) rats: correlation with pancreatic beta-cell function

Journal of Anatomy 217(5):624-630, 2010

Paulsen SJ, Vrang N, Larsen LK, Larsen PJ, Jelsing J.

Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides

Progress in Neurobiology 92(3):442–462, 2010

Vrang N, Larsen PJ

The imprinted gene neuronatin is regulated by metabolic status and associated with obesity

Obesity (Silver Spring) 18(7):1289–1296, 2010

The effect of leptin receptor deficiency and fasting on cannabinoid receptor 1 mRNA expression in the rat hypothalamus, brainstem and nodose ganglion

Neuroscience Letters 463(2):125–129, 2009

Jelsing J, Larsen PJ, Vrang N

Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2

Brain Research Bulletin 78:202–10, 2009

Jelsing J, Galzin AM, Guillot E, Pruniaux MP, Larsen PJ, Vrang N